Details

Autor(en) / Beteiligte

• Criner, Gerard J
• Celli, Bartolome R
• Brightling, Christopher E
• Agusti, Alvar
• Papi, Alberto
• Singh, Dave
• Sin, Don D
• Vogelmeier, Claus F
• Sciurba, Frank C
• Bafadhel, Mona
• Backer, Vibeke
• Kato, Motokazu
• Ramírez-Venegas, Alejandra
• Wei, Yu-Feng
• Bjermer, Leif
• Shih, Vivian H
• Jison, Maria
• O’Quinn, Sean
• Makulova, Natalya
• Newbold, Paul
• Goldman, Mitchell
• Martin, Ubaldo J

Titel

Benralizumab for the Prevention of COPD Exacerbations

Ist Teil von

• The New England journal of medicine, 2019-09, Vol.381 (11), p.1023-1034

Ort / Verlag

United States: Massachusetts Medical Society

Erscheinungsjahr

2019

Link zum Volltext

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• In patients with moderate to very severe COPD and a blood eosinophil count of 220 cells per cubic millimeter or greater, treatment with benralizumab, an anti–interleukin-5 receptor antibody (administered at doses similar to or higher than those used for severe asthma) did not change the rate of COPD exacerbations.